These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 12413508

  • 1. Neurohumoral prediction of left-ventricular morphologic response to beta-blockade with metoprolol in chronic left-ventricular systolic heart failure.
    Groenning BA, Nilsson JC, Hildebrandt PR, Kjaer A, Fritz-Hansen T, Larsson HB, Sondergaard L.
    Eur J Heart Fail; 2002 Oct; 4(5):635-46. PubMed ID: 12413508
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations.
    Groenning BA, Nilsson JC, Sondergaard L, Kjaer A, Larsson HB, Hildebrandt PR.
    Eur J Heart Fail; 2001 Dec; 3(6):699-708. PubMed ID: 11738222
    [Abstract] [Full Text] [Related]

  • 3. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
    Colucci WS, Kolias TJ, Adams KF, Armstrong WF, Ghali JK, Gottlieb SS, Greenberg B, Klibaner MI, Kukin ML, Sugg JE, REVERT Study Group.
    Circulation; 2007 Jul 03; 116(1):49-56. PubMed ID: 17576868
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT, White M, Yan AT, Yusuf S, Rouleau JL, Maggioni AP, Hall C, Latini R, Afzal R, Floras J, Masson S, McKelvie RS, Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Investigators.
    Am J Cardiol; 2005 Sep 01; 96(5):698-704. PubMed ID: 16125499
    [Abstract] [Full Text] [Related]

  • 5. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure.
    Groenning BA, Nilsson JC, Sondergaard L, Fritz-Hansen T, Larsson HB, Hildebrandt PR.
    J Am Coll Cardiol; 2000 Dec 01; 36(7):2072-80. PubMed ID: 11127443
    [Abstract] [Full Text] [Related]

  • 6. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction.
    Stanek B, Frey B, Hülsmann M, Berger R, Sturm B, Strametz-Juranek J, Bergler-Klein J, Moser P, Bojic A, Hartter E, Pacher R.
    J Am Coll Cardiol; 2001 Aug 01; 38(2):436-42. PubMed ID: 11499735
    [Abstract] [Full Text] [Related]

  • 7. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
    Bergström A, Andersson B, Edner M, Nylander E, Persson H, Dahlström U.
    Eur J Heart Fail; 2004 Jun 01; 6(4):453-61. PubMed ID: 15182771
    [Abstract] [Full Text] [Related]

  • 8. Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
    Shinohara H, Fukuda N, Soeki T, Sakabe K, Onose Y, Tamura Y.
    Heart Vessels; 2002 Dec 01; 17(2):47-52. PubMed ID: 12541093
    [Abstract] [Full Text] [Related]

  • 9. Pronounced improvement in systolic and diastolic ventricular long axis function after treatment with metoprolol.
    Grüner Sveälv B, Täng MS, Waagstein F, Andersson B.
    Eur J Heart Fail; 2007 Dec 01; 9(6-7):678-83. PubMed ID: 17448723
    [Abstract] [Full Text] [Related]

  • 10. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study.
    Circulation; 2000 Feb 01; 101(4):378-84. PubMed ID: 10653828
    [Abstract] [Full Text] [Related]

  • 11. Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated cardiomyopathy.
    Clements IP, Miller WL.
    Am Heart J; 2001 Feb 01; 141(2):259. PubMed ID: 11174349
    [Abstract] [Full Text] [Related]

  • 12. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
    Udelson JE, Feldman AM, Greenberg B, Pitt B, Mukherjee R, Solomon HA, Konstam MA.
    Circ Heart Fail; 2010 May 01; 3(3):347-53. PubMed ID: 20299607
    [Abstract] [Full Text] [Related]

  • 13. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C, Maria Sironi A, Favilli B, Poletti R, Prontera C, Ripoli A, Lombardi M, Emdin M.
    Int J Cardiol; 2005 Sep 15; 104(1):39-45. PubMed ID: 16137508
    [Abstract] [Full Text] [Related]

  • 14. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
    Han SW, Choi SW, Ryu KH, Kim HJ, Kim SH, Shim WJ, Cha TJ, Choi DJ, Kim YJ, Yoo BS, Kim JH, Hwang KK, Jeon H, Shin MS.
    Cardiovasc Ther; 2016 Jun 15; 34(3):172-9. PubMed ID: 27003232
    [Abstract] [Full Text] [Related]

  • 15. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
    Waagstein F, Strömblad O, Andersson B, Böhm M, Darius M, Delius W, Goss F, Osterziel KJ, Sigmund M, Trenkwalder SP, Wahlqvist I.
    Eur J Heart Fail; 2003 Oct 15; 5(5):679-91. PubMed ID: 14607208
    [Abstract] [Full Text] [Related]

  • 16. Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function.
    van Kraaij DJ, Jansen RW, Sweep FC, Hoefnagels WH.
    Eur J Heart Fail; 2003 Jan 15; 5(1):47-53. PubMed ID: 12559215
    [Abstract] [Full Text] [Related]

  • 17. Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.
    Becher PM, Lindner D, Miteva K, Savvatis K, Zietsch C, Schmack B, Van Linthout S, Westermann D, Schultheiss HP, Tschöpe C.
    Hypertension; 2012 May 15; 59(5):949-57. PubMed ID: 22493071
    [Abstract] [Full Text] [Related]

  • 18. Baseline characteristics of patients recruited in the AREA IN-CHF study (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure).
    Boccanelli A, Cacciatore G, Mureddu GF, de Simone G, Clemenza F, De Maria R, Di Lenarda A, Gavazzi A, Latini R, Masson S, Porcu M, Vanasia M, Gonzini L, Maggioni AP.
    J Cardiovasc Med (Hagerstown); 2007 Sep 15; 8(9):683-91. PubMed ID: 17700397
    [Abstract] [Full Text] [Related]

  • 19. Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol.
    Eichhorn EJ, Heesch CM, Risser RC, Marcoux L, Hatfield B.
    J Am Coll Cardiol; 1995 Jan 15; 25(1):154-62. PubMed ID: 7798494
    [Abstract] [Full Text] [Related]

  • 20. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.
    Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, Cotts WG, Klocke FJ, Bonow RO, Judd RM, Gheorghiade M, Kim RJ.
    Circulation; 2003 Oct 21; 108(16):1945-53. PubMed ID: 14557364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.